Skip to main content
. Author manuscript; available in PMC: 2020 Dec 2.
Published in final edited form as: J Am Med Dir Assoc. 2020 Jun 16;21(12):1937–1943.e2. doi: 10.1016/j.jamda.2020.04.007

Table 3.

Point Prevalence of MDRO Carriage at Participating Nursing Homes

Nursing Home Number of Residents Swabbed Chart History of Any MDRO, n (%) MDRO Carriage, n (%) MRSA Carriage, n (%)
VRE Carriage, n (%) ESBL Carriage, n (%) CRE Carriage, n (%) Newly Detected MDRO, n (%) Newly Detected MDRO Without Any Prior MDRO History, n (%) Newly Detected MDRO With Prior MDRO History, n (%)
Any Nares Skin
1 50 7 (14) 35 (70) 23 (46) 19 (38) 14 (28) 10 (20) 13 (26) 0 (0) 34 (68) 29 (67) 5 (71)
2 50 6 (12) 31 (62) 23 (46) 19 (38) 15 (30) 2 (4) 12 (24) 3 (6) 30 (60) 28 (64) 2 (33)
3 50 8 (16) 30 (60) 18 (36) 14 (28) 11 (22) 3 (6) 17 (34) 1 (2) 30 (60) 26 (62) 4 (50)
4 50 12 (24) 30 (60) 24 (48) 20 (40) 21 (42) 7 (14) 15 (30) 4 (8) 29 (58) 18 (47) 11 (92)
5 50 10 (20) 30 (60) 24 (48) 21 (42) 17 (34) 5 (10) 9 (18) 0 (0) 27 (54) 22 (55) 5 (50)
6 50 1 (2) 30 (60) 27 (54) 18 (36) 23 (46) 3 (6) 7 (14) 0 (0) 30 (60) 29 (59) 1 (100)
7 50 6 (12) 30 (60) 22 (44) 16 (32) 16 (32) 7 (14) 9 (18) 0 (0) 29 (58) 26 (59) 3 (50)
8 50 5 (10) 29 (58) 20 (40) 18 (36) 13 (26) 2 (4) 11 (22) 1 (2) 27 (54) 25 (56) 2 (40)
9 50 0 (0) 29 (58) 27 (54) 23 (47) 20 (40) 0 (0) 4 (8) 0 (0) 29 (58) 29 (58) 0
10 50 6 (12) 29 (58) 23 (46) 20 (40) 13 (26) 5 (10) 10 (20) 0 (0) 27 (54) 23 (52) 4 (67)
11 50 5 (10) 27 (54) 18 (36) 13 (26) 15 (30) 15 (30) 5 (10) 0 (0) 26 (52) 23 (51) 3 (60)
12 50 8 (16) 26 (52) 16 (32) 13 (26) 11 (22) 11 (22) 10 (20) 1 (2) 24 (48) 20 (48) 4 (50)
13 50 8 (16) 25 (50) 22 (44) 20 (40) 14 (28) 1 (2) 6 (12) 1 (2) 21 (42) 18 (43) 3 (38)
14 50 2 (4) 25 (50) 25 (50) 15 (30) 16 (32) 0 (0) 2 (4) 0 (0) 25 (50) 24 (50) 1 (50)
15 50 5 (10) 25 (50) 21 (42) 17 (34) 18 (36) 4 (8) 8 (16) 0 (0) 24 (48) 22 (49) 2 (40)
16 50 17 (34) 24 (48) 15 (30) 14 (28) 7 (14) 1 (2) 16 (32) 0 (0) 18 (36) 14 (42) 4 (24)
17 50 11 (22) 23 (46) 18 (36) 16 (32) 5 (10) 4 (8) 8 (16) 0 (0) 19 (38) 15 (38) 4 (36)
18 50 12 (24) 23 (46) 21 (42) 16 (32) 15 (30) 1 (2) 6 (12) 0 (0) 18 (36) 15 (39) 3 (25)
19 50 8 (16) 21 (42) 12 (24) 8 (17) 10 (20) 7 (14) 5 (10) 0 (0) 17 (34) 16 (38) 1 (13)
20 50 1 (2) 21 (42) 15 (30) 12 (24) 7 (14) 0 (0) 11 (22) 1 (2) 21 (42) 20 (41) 1 (100)
21 50 8 (16) 19 (38) 15 (30) 9 (18) 11 (22) 1 (2) 3 (6) 0 (0) 17 (34) 14 (33) 3 (38)
22 50 11 (22) 19 (38) 14 (28) 12 (24) 8 (16) 1 (2) 8 (16) 0 (0) 13 (26) 13 (33) 0 (0)
23 50 5 (10) 19 (38) 15 (30) 15 (30) 8 (16) 0 (0) 8 (16) 0 (0) 16 (32) 16 (36) 0 (0)
24 50 10 (20) 18 (36) 15 (30) 12 (24) 7 (14) 0 (0) 8 (16) 0 (0) 17 (34) 12 (30) 5 (50)
25 50 2 (4) 17 (34) 10 (20) 7 (14) 6 (12) 4 (8) 6 (12) 0 (0) 16 (32) 15 (31) 1 (50)
26 50 4 (8) 17 (34) 11 (22) 10 (20) 3 (6) 3 (6) 4 (8) 0 (0) 16 (32) 14 (30) 2 (50)
27 50 2 (4) 16 (32) 13 (26) 11 (22) 8 (16) 2 (4) 6 (12) 1 (2) 15 (30) 14 (29) 1 (50)
28 50 0 (0) 12 (24) 11 (22) 4 (8) 9 (18) 0 (0) 1 (2) 0 (0) 12 (24) 12 (24) 0
Total residents 1400 180 (13) 680 (49) 518 (37) 412 (29) 341 (24) 99 (7) 228 (16) 13 (1) 627 (45) 552 (45)* 75 (42)
Facility mean % (SD) 13 (0.08) 49 (0.11) 37 (0.10) 29 (0.09) 24 (0.10) 7 (0.08) 16 (0.08) 1 (0.02) 45 (0.12) 45 (0.12) 47 (0.25)
Facility median % (range) 12 (0–34) 50 (24–70) 36 (20–54) 30 (8–47) 24 (6–46) 5 (0–30) 16 (2–34) 0 (0–8) 45 (24–68) 45 (24–67) 50 (0–100)
*

Total MDRO detected among residents without a documented history of MDRO (n = 1220).

Total newly detected MDRO among residents with a documented history of MDRO (n = 180).